EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Patient Characteristics, Diagnostic Testing Utilization, and Antifungal Prescribing Pattern for Onychomycosis in the USA: A Cohort Study Using DataDerm, 2016–2022

Aditya K Gupta, Tong Wang, Anh N Tran

Skin Appendage Disorders · 29.08.2024 · 1-9

DOI: 10.1159/000540704 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Skin Appendage Disorders, online erschienen am 29.08.2024. Verfasst von Aditya K Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Onychomycosis is a complex nail disease that is commonly seen in daily practice.

Methods

Electronic health records of clinically diagnosed onychomycosis patients were extracted using DataDerm – a dermatology data registry hosted by the American Academy of Dermatology – spanning from the year 2016 to 2022.

Results

Regardless of age, an increasing trend in patient volume was observed in the Southern US region, which accounted for 50.7–56.9% of onychomycosis patients in 2022. A coinfection of tinea pedis was present among 15.6–22.5% of patients. Diagnostic testing was infrequently utilized with less than one-quarter of patients having a histopathologic examination (12.7–21.9%) followed by fungal culture (5.5–8.2%) and direct microscopic examination (3.3–6.0%). Treatments were infrequently prescribed, accounting for less than one-quarter of patients (orals, terbinafine: 20.8–29.1%, fluconazole: 12.9–16.5%; topicals, efinaconazole: 3.2–13.8%); over 30% of treated patients received a combination regimen or experienced switching of treatments. Prescribing patterns did not significantly differ in vulnerable patient groups such as elderly patients and in patients with concomitant tinea pedis. Patients receiving a topical and/or oral antifungal prescription were frequently not tested to confirm the onychomycosis diagnosis (76.9%).

Conclusion

Our findings add to a growing body of literature calling for the improvement of onychomycosis management practices.

Schlagwörter

Stichwörter der Autor:innen

DermatomycosisNail fungusOnychomycosisTinea unguium

Autor:innen und Institutionen

  • Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Mediprobe Research Inc., London, ON, Canada.
  • Department of Science and Quality, American Academy of Dermatology [AAD], Rosemont, IL, USA.

Zitieren

APA

Gupta, A. K., Wang, T., & Tran, A. N. (2024). Patient Characteristics, Diagnostic Testing Utilization, and Antifungal Prescribing Pattern for Onychomycosis in the USA: A Cohort Study Using DataDerm, 2016–2022. Skin Appendage Disorders, 1-9. https://doi.org/10.1159/000540704

Vancouver

Gupta AK, Wang T, Tran AN. Patient Characteristics, Diagnostic Testing Utilization, and Antifungal Prescribing Pattern for Onychomycosis in the USA: A Cohort Study Using DataDerm, 2016–2022. Skin Appendage Disorders. 2024:1-9. doi:10.1159/000540704

BibTeX
@article{Gupta2024,
  author = {Gupta, Aditya K and Wang, Tong and Tran, Anh N},
  title = {Patient Characteristics, Diagnostic Testing Utilization, and Antifungal Prescribing Pattern for Onychomycosis in the USA: A Cohort Study Using DataDerm, 2016–2022},
  journal = {Skin Appendage Disorders},
  year = {2024},
  pages = {1--9},
  doi = {10.1159/000540704}
}
Kostenlos starten →